114 related articles for article (PubMed ID: 38682188)
21. Expression of ZNF148 in different developing stages of colorectal cancer and its prognostic value: a large Chinese study based on tissue microarray.
Gao XH; Liu QZ; Chang W; Xu XD; Du Y; Han Y; Liu Y; Yu ZQ; Zuo ZG; Xing JJ; Cao G; Fu CG
Cancer; 2013 Jun; 119(12):2212-22. PubMed ID: 23576061
[TBL] [Abstract][Full Text] [Related]
22. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer.
Wu HK; Liu C; Fan XX; Wang H; Zhou L
Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451
[TBL] [Abstract][Full Text] [Related]
23. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
Zou G; Wang R; Wang M
Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-38 in colorectal cancer: a potential role in precision medicine.
Chen F; Zhang F; Tan Z; Hambly BD; Bao S; Tao K
Cancer Immunol Immunother; 2020 Jan; 69(1):69-79. PubMed ID: 31786620
[TBL] [Abstract][Full Text] [Related]
25. Gremlin1 expression associates with serrated pathway and favourable prognosis in colorectal cancer.
Pelli A; Väyrynen JP; Klintrup K; Mäkelä J; Mäkinen MJ; Tuomisto A; Karttunen TJ
Histopathology; 2016 Nov; 69(5):831-838. PubMed ID: 27257976
[TBL] [Abstract][Full Text] [Related]
26. High expression of meningioma 1 is correlated with reduced survival rates in colorectal cancer patients.
Ho YJ; Liu FC; Chang J; Shi B; Yeh KT; Lin YM; Lu JW
Acta Histochem; 2019 Jul; 121(5):628-637. PubMed ID: 31133374
[TBL] [Abstract][Full Text] [Related]
27. Correlated non-nuclear COX2 and low HER2 expression confers a good prognosis in colorectal cancer.
Zhou FF; Huang R; Jiang J; Zeng XH; Zou SQ
Saudi J Gastroenterol; 2018; 24(5):301-306. PubMed ID: 29873317
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
[TBL] [Abstract][Full Text] [Related]
29. Musashi2 as a novel predictive biomarker for liver metastasis and poor prognosis in colorectal cancer.
Zong Z; Zhou T; Rao L; Jiang Z; Li Y; Hou Z; Yang B; Han F; Chen S
Cancer Med; 2016 Apr; 5(4):623-30. PubMed ID: 26775684
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of gene DEP domain containing 1 and its clinical prognostic significance in colorectal cancer.
Shen X; Han J
J Clin Lab Anal; 2020 Dec; 34(12):e23634. PubMed ID: 33140894
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of the upregulated osteopontin mRNA expression in human colorectal cancer.
Likui W; Hong W; Shuwen Z
J Gastrointest Surg; 2010 Jan; 14(1):74-81. PubMed ID: 19763701
[TBL] [Abstract][Full Text] [Related]
33. [Expression of microRNA-152 in colorectal cancer and its relationship with prognosis].
Wang Y; Yuan W; Ma X; Ma J
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):763-766. PubMed ID: 27784461
[No Abstract] [Full Text] [Related]
34. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
35. Over-expression of SOX8 predicts poor prognosis in colorectal cancer: A retrospective study.
Wang Y; Yang W; Liu T; Bai G; Liu M; Wang W
Medicine (Baltimore); 2019 Jul; 98(27):e16237. PubMed ID: 31277140
[TBL] [Abstract][Full Text] [Related]
36. Low expression of chloride channel accessory 1 predicts a poor prognosis in colorectal cancer.
Yang B; Cao L; Liu J; Xu Y; Milne G; Chan W; Heys SD; McCaig CD; Pu J
Cancer; 2015 May; 121(10):1570-80. PubMed ID: 25603912
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of BRAF/MIR-17 signature and B-Raf protein expression in patients with colorectal cancer: A pilot study.
Ibrahiem AT; Fawzy MS; Abu AlSel BT; Toraih EA
J Clin Lab Anal; 2021 Mar; 35(3):e23679. PubMed ID: 33296098
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Significance of Serum Lactic Acid, Lactate Dehydrogenase, and Albumin Levels in Patients with Metastatic Colorectal Cancer.
Wei Y; Xu H; Dai J; Peng J; Wang W; Xia L; Zhou F
Biomed Res Int; 2018; 2018():1804086. PubMed ID: 30627541
[TBL] [Abstract][Full Text] [Related]
39. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
40. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]